Human in vivo kinetic studies using stable isitopr

Human in vivo kinetic studies using stable isitopr - tracer studies using stable isotope

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011758

Enrollment

Registered

2013-10-01

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidemia

Interventions

administration of lipid-lowering agents

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dyslipidemic patients fulfilling at least one of the following criteria 1) LDL-C>140mg/dl 2) TG>150mg/dl 3) HDL-C<40mg/dl

Exclusion criteria

Exclusion criteria: secondary hyperlipidemia

Design outcomes

Primary

Measure	Time frame
metabolic parameters	—

Countries

Japan

Contacts

Public ContactKatsunori Ikewaki

National Defense Medical College Division of Neurology, Anti-aging, and Vascular Medicine

kikewaki@hotmail.com04-2995-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026